Genetically Encoded Tyrosine Sulfation for Homogeneous Recombinant Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to express recombinant proteins in eukaryotic hosts with homogeneous tyrosine sulfation, as endogenous sulfotransferases cannot keep up with high expression levels, leading to heterogeneous modification and difficulty in evaluating the roles of individual sulfations.
Innovation Solution
Development of an engineered tyrosyl RNA synthetase/tRNA pair that co-translationally incorporates tyrosine analogs, specifically O-sulfotyrosine, in response to UAG codons in Escherichia coli and mammalian cells, using variant E. coli tyrosyl-tRNA synthetase (EcTyr-RS) to preferentially aminoacylate tyrosyl tRNA with tyrosine analogs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If proteins are overexpressed in eukaryotic hosts, then productivity increases, but the endogenous sulfotransferases cannot keep up with high expression levels, leading to heterogeneous modification
Solution Approach 1:
The patent introduces an engineered tyrosyl-tRNA synthetase as an intermediary enzyme that directly charges tRNA with O-sulfotyrosine during translation, bypassing the rate-limiting step of endogenous sulfotransferases. This mediator enables co-translational incorporation of sulfated tyrosine, ensuring homogeneous modification even at high protein expression levels.
Solution Approach 2:
The system performs preliminary sulfation by incorporating O-sulfotyrosine directly during translation elongation, rather than relying on post-translational modification. This advance action ensures that sulfation occurs at the same rate as protein synthesis, maintaining homogeneity throughout the protein production process.
2Adaptability or versatility
If multiple distinct sulfation sites are present in a protein, then the complexity of the protein increases, but it is not possible to homogenously modify a subset of these sites
Solution Approach 1:
The patent applies local quality by using site-specific unnatural amino acid incorporation at selected tyrosine positions through codon replacement, while leaving other tyrosine residues unaffected. This enables selective sulfation at specific locations within the protein, achieving homogeneous modification of chosen sites while maintaining control over multi-site proteins.
Solution Approach 2:
The approach segments the sulfation process by treating each tyrosine residue independently through site-specific codon substitution (e.g., UAG amber stop codons). This segmentation allows individual control over which tyrosine residues receive O-sulfotyrosine, enabling precise manipulation of multi-site sulfation patterns.
3Ease of manufacture
If recombinant expression is performed in common eukaryotic hosts, then ease of manufacture is improved, but incomplete sulfation of native sites occurs
Solution Approach 1:
The patent changes the chemical parameter of tyrosine by incorporating O-sulfotyrosine (an unnatural amino acid with a sulfate group) instead of relying on the enzymatic activity of endogenous sulfotransferases. This parameter change transforms the sulfation process from enzyme-dependent to translation-dependent, ensuring complete and homogeneous sulfation in standard eukaryotic expression systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the recombinant expression of eukaryotic proteins with precise sulfation at selected sites, allowing for the study of sulfation consequences and the development of sulfated antibodies with enhanced pathogen targeting.
Implementation Method 1
a variant E. coli tyrosyl-tRNA synthetase (EcTyr-RS) wherein the variant EcTyr-RS preferentially aminoacylates an E. coli tyrosyl tRNA (Ec-tRNATyr) with a tyrosine analog over the naturally-occurring tyrosine amino acid
Data Source
AI summary
An engineered tyrosyl-tRNA synthetase/tRNA pair that co-translationally incorporates O-sulfotyrosine in response to UAG codons in E. coli and mammalian cells is described herein. This platform enables recombinant expression of eukaryotic proteins homogeneously sulfated at chosen sites.